Dividend $0.25 Ex-Dividend Date Nov 18, 2024 Short Interest 36.69M 03/31/25 % of Float Shorted 5.16% Average Volume 22.86M Performance 5 Day 0.56% 1 Month -2.34% 3 Month -13.42% YTD 16.19% 1 Year -40.57% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 16 Full...
Levered Free Cash Flow4,330 (M) PE Ratio-1.1 PEG Ratio0 Price to Book value0.97 Price to Sales0.06 Price to Cash Flow8.36 Stock Dividends Dividend0.25 Forward Dividend0 Dividend Yield2.2% Dividend Pay DateInvalid DateTime. Ex-Dividend DateInvalid DateTime....
and we intend to invest in these stores over the next several years. Part of the funding for this investment will come from accelerating the closure of underperforming stores. We expect
very strong clear messaging in the marketplace from us and others that would point to the fact that the way that retail pharmacies will create value in the next 10 years isn't going to simply be lowering the cost of -- the unit cost of the drugs...
James, the dividend payout ratio is really, really high this year. I think we calculated at something like 75%. You’ve talked about growing the dividend. That’s certainly a goal, remaining investment grade and having the cash flow improve dramatically next year. And I guess I want to ...
Dividend $0.25 Ex-Dividend Date Nov 18, 2024 Short Interest 67.05M 02/14/25 % of Float Shorted 9.45% Average Volume 25.99M Performance 5 Day -2.77% 1 Month 11.88% 3 Month 23.63% YTD 18.60% 1 Year -47.33% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 20 Full ...
we also continue to evaluate the appropriateness and size of our dividend as part of our capital allocation policy. Our priority for fiscal 2025 is to stabilize our core performance while we make progress on the longer-term strategic and operational turnaround. Our progress to date is reflected ...